Invention Grant
- Patent Title: Mutagenic nucleoside analogs for the treatment of viral disease
- Patent Title (中): 诱变核苷类似物用于治疗病毒性疾病
-
Application No.: US11353489Application Date: 2006-02-13
-
Publication No.: US07648967B2Publication Date: 2010-01-19
- Inventor: Ling Li , Alexander Gall , Richard Daifuku
- Applicant: Ling Li , Alexander Gall , Richard Daifuku
- Applicant Address: US WA Redmond
- Assignee: Koronis Pharmaceuticals, Incorporated
- Current Assignee: Koronis Pharmaceuticals, Incorporated
- Current Assignee Address: US WA Redmond
- Agency: Townsend and Townsend and Crew LLP
- Main IPC: A61K31/70
- IPC: A61K31/70 ; C07H19/167 ; C07H19/173 ; C07H19/20 ; C12P19/40 ; C12P19/30 ; C12P19/34
Abstract:
The present invention relates to methods of treating viral disease using mutagenic nucleoside analogs. In particular, the invention provides isoguanosine nucleosides and derivatives thereof as well a method of increasing the mutation rate of a virus such as bovine viral diarrhea virus (BVDV) and hepatitis C virus (HCV).
Public/Granted literature
- US20060142240A1 Mutagenic nucleoside analogs for the treatment of viral disease Public/Granted day:2006-06-29
Information query
